Please login to the form below
PaxVax
This page shows the latest PaxVax news and features for those working in and with pharma, biotech and healthcare.
Givlaari, Rybelsus lead crowded CHMP recommendations
The CHMP also recommended PaxVax’s cholera vaccine Vaxchora for prophylaxis against choleam and Eli Lilly’s new fast-acting mealtime insulin Liumjev, to improve glycemic control in diabetes in adults.
Latest news
-
FDA approves first cholera vaccine in US
PaxVax was awarded breakthrough status and priority review for Vaxchora, reflecting the fact that there are few options available to travellers from the US who wish to protect against cholera. ... PaxVax said it is also working to make its vaccines
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Kala names Howard Rosen as chairman
Rosen has held several senior roles at major biotechs, including his current positions on the board of directors at AcelRX, Aldea, Entrega and PaxVax, where he is also chairman.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Vivotif from PaxVax: Helping to keep you safe
Therapy area: Infections and Infestations. View the PMHub profile for: Page &Page and Partners.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
